Atrial fibrillation ablation as first-line therapy for patients with heart failure with reduced ejection fraction (HFrEF): evaluating the impact on patient survival.
Hadi YounesCharbel NoujaimMario MekhaelNour ChoumanAla AssafOmar KreidiehChanho LimNassir F MarroucheEoin DonnellanPublished in: Expert review of cardiovascular therapy (2023)
An appropriate patient selection strategy for patients with HFrEF could be the next step in determining which patients might benefit most from catheter ablation. Future atrial fibrillation management may incorporate digital health and pulsed-field ablation.
Keyphrases
- catheter ablation
- atrial fibrillation
- left atrial
- left atrial appendage
- end stage renal disease
- oral anticoagulants
- case report
- newly diagnosed
- healthcare
- ejection fraction
- direct oral anticoagulants
- heart failure
- chronic kidney disease
- prognostic factors
- percutaneous coronary intervention
- mitral valve
- health information
- current status
- left ventricular
- coronary artery disease
- climate change
- social media
- acute coronary syndrome
- health promotion